Micro-metastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedureTJAN-HEIJNEN, Vivianne C. G; BULT, Peter; DE WIDT-LEVERT, Louise M et al.Breast cancer research and treatment. 2001, Vol 70, Num 2, pp 81-88, issn 0167-6806Article

E1AF expression levels are not associated with prognosis in human breast cancerSPANS, Paul N; MANDERS, Peggy; HEUVEL, Joop J. T. M et al.Breast cancer research and treatment. 2003, Vol 79, Num 1, pp 129-131, issn 0167-6806, 3 p.Article

Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: A prognostic marker for good clinical outcome in human breast carcinomaSPAN, Paul N; SWEEP, C. G. J; MANDERS, Peggy et al.Cancer. 2003, Vol 97, Num 11, pp 2710-2715, issn 0008-543X, 6 p.Article

Vascular endothelial growth factor is associated with the efficacy of endocrine therapy in patients with advanced breast carcinomaMANDERS, Peggy; BEEX, Louk V. A. M; TJAN-HEIJNEN, Vivianne C. G et al.Cancer. 2003, Vol 98, Num 10, pp 2125-2132, issn 0008-543X, 8 p.Article

The prognostic value of proliferation in lymph-node-negative breast cancer patients is age dependentBAAK, Jan P. A; VAN DIEST, Paul J; VOORHORST, Feja J et al.European journal of cancer (1990). 2007, Vol 43, Num 3, pp 527-535, issn 0959-8049, 9 p.Article

Fatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high-dose chemotherapy : A longitudinal studyNIEBOER, Peter; BUIJS, Ciska; MULDER, Nanno H et al.Journal of clinical oncology. 2005, Vol 23, Num 33, pp 8296-8304, issn 0732-183X, 9 p.Article

Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancerSPAN, Paul N; MANDERS, Peggy; HEUVEL, Joop J et al.Oncogene (Basingstoke). 2002, Vol 21, Num 55, pp 8506-8509, issn 0950-9232, 4 p.Article

Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer : A randomized studyKLIJN, Jan G. M; BEEX, Louk V. A. M; SEYNAEVE, Carolien et al.Journal of the National Cancer Institute. 2000, Vol 92, Num 11, pp 903-911, issn 0027-8874Article

Complex of urokinase-type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node-negative breast carcinomaMANDERS, Peggy; TJAN-HEIJNEN, Vivianne C. G; SPAN, Paul N et al.Cancer. 2004, Vol 101, Num 3, pp 486-494, issn 0008-543X, 9 p.Article

Tissue inhibitors of metalloproteinase expression in human breast cancer: TIMP-3 is associated with adjuvant endocrine therapy success. CommentarySPAN, Paul N; LINDBERG, Raija L. P; MANDERS, Peggy et al.Journal of pathology. 2004, Vol 202, Num 4, pp 391-394, issn 0022-3417, 12 p.Article

Molecular Beacon reverse transcription-PCR of human chorionic gonadotropin-ss-3, -5, and -8 mrnas has prognostic value in breast cancerSPAN, Paul N; MANDERS, Peggy; HEUVEL, Joop J. T. M et al.Clinical chemistry (Baltimore, Md.). 2003, Vol 49, Num 7, pp 1074-1080, issn 0009-9147, 7 p.Article

Diverging breast cancer mortality rates in relation to screening? A comparison of Nijmegen to Arnhem and The Netherlands, 1969-1997BROEDERS, Mireille J. M; PEER, Petronella G. M; STRAATMAN, Huub et al.International journal of cancer. 2001, Vol 92, Num 2, pp 303-308, issn 0020-7136Article

Pitfall in HPLC assay for urinary metanephrines: An unusual type of interference caused by methenamine intakeVAN LAARHOVEN, Hanneke W. M; WILLEMSEN, Jacques J; ROSS, H. Alec et al.Clinical chemistry (Baltimore, Md.). 2004, Vol 50, Num 6, pp 1097-1099, issn 0009-9147, 3 p.Article

Predictive impact of urokinase-type plasminogen activator: Plasminogen activator inhibitor type-1 complex on the efficacy of adjuvant systemic therapy in primary breast cancerMANDERS, Peggy; TJAN-HEIJNEN, Vivianne C. G; SPAN, Paul N et al.Cancer research (Baltimore). 2004, Vol 64, Num 2, pp 659-664, issn 0008-5472, 6 p.Article

The complex between urokinase-type plasminogen activator (uPA) and its type-I inhibitor (PAI-I) independently predicts response to first-line endocrine therapy in advanced breast cancerMANDERS, Peggy; G.TJAN-HEIJNEN, Vivianne C; SPAN, Paul N et al.Thrombosis and haemostasis. 2004, Vol 91, Num 3, pp 514-521, issn 0340-6245, 8 p.Conference Paper

Tamoxifen resistance in breast cancer : Elucidating mechanismsDORSSERS, Lambert C. J; VAN DER FLIER, Silvia; BRINKMAN, Arend et al.Drugs (Basel). 2001, Vol 61, Num 12, pp 1721-1733, issn 0012-6667Article

High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancerRODENHUIS, Sjoerd; BONTENBAL, Marijke; TENVERGERT, Elisabeth M et al.The New England journal of medicine. 2003, Vol 349, Num 1, pp 7-16, issn 0028-4793, 10 p.Article

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predispositionKRIEGE, Mieke; BREKELMANS, Cecile T. M; MULLER, Sara H et al.The New England journal of medicine. 2004, Vol 351, Num 5, pp 427-437, issn 0028-4793, 11 p.Article

Survivin is an independent prognostic marker for risk stratification of breast cancer patientsSPAN, Paul N; SWEEP, Fred C. G. J; WIEGERINCK, Erwin T. G et al.Clinical chemistry (Baltimore, Md.). 2004, Vol 50, Num 11, pp 1986-1993, issn 0009-9147, 8 p.Article

Prospective multicenter validation of the independent prognostic value of the mitotic activity index in lymph node-negative breast cancer patients younger than 55 yearsBAAK, Jan P. A; VAN DIEST, Paul J; VOORHORST, Feja J et al.Journal of clinical oncology. 2005, Vol 23, Num 25, pp 5993-6001, issn 0732-183X, 9 p.Article

Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival timeSPAN, Paul N; WAANDERS, Esmé; MANDERS, Peggy et al.Journal of clinical oncology. 2004, Vol 22, Num 4, pp 691-698, issn 0732-183X, 8 p.Article

5-FU-induced peripheral neuropathy: a rare complication of a well-known drugVAN LAARHOVEN, Hanneke W. M; VERSTAPPEN, Carla C. P; BEEX, Louk V. A. M et al.Anticancer research. 2003, Vol 23, Num 1B, pp 647-648, issn 0250-7005, 2 p.Article

Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancerFOEKENS, John A; ATKINS, David; TJAN-HEIJNEN, Vivianne C. G et al.Journal of clinical oncology. 2006, Vol 24, Num 11, pp 1665-1671, issn 0732-183X, 7 p.Article

Vascular endothelial growth factor independently predicts the efficacy of postoperative radiotherapy in node-negative breast cancer patientsMANDERS, Peggy; SWEEP, Fred C. G. J; TJAN-HEIJNEN, Vivianne C. G et al.Clinical cancer research. 2003, Vol 9, Num 17, pp 6363-6370, issn 1078-0432, 8 p.Article

Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patientsLOOK, Maxime P; VAN PUTTEN, Wim L. J; SWEEP, C. G. J. Fred et al.Journal of the National Cancer Institute. 2002, Vol 94, Num 2, pp 116-128, issn 0027-8874Article